In a major setback for drug maker QRxPharma Ltd. (QRX), its shares plunged the most in Sydney trading since its initial share sale in 2007 after the advisors of U.S. Food and Drug Administration advisers denied approving its painkiller that combines two opioids. The company’s shares fell 80 percent to A$0.14 at the close of trading in Sydney. This was QRxPharma’s largest drop since it began … [Read more...]
You are here: Home / Archives for Sydney trading